(Q43137532)

14 November 2017

title

The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens (English)

1 reference

14 November 2017

0 references

Chittappen K Prajeeth

1

1 reference

14 November 2017

Adan Chari Jirmo

2

1 reference

14 November 2017

Jayendra Kumar Krishnaswamy

3

1 reference

14 November 2017

Thomas Ebensen

4

1 reference

14 November 2017

Carlos A Guzman

5

1 reference

14 November 2017

Siegfried Weiss

6

1 reference

14 November 2017

Hannelore Constabel

7

1 reference

14 November 2017

Reinhold E Schmidt

8

1 reference

14 November 2017

Georg M N Behrens

9

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

European Journal of Immunology

14 November 2017

published in

1 reference

14 November 2017

volume

40

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

1272-1283

1 reference

Antigen presentation by monocytes and monocyte-derived cells

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Helper requirements for generation of effector CTL to islet beta cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

CD36 Is Differentially Expressed by CD8+ Splenic Dendritic Cells But Is Not Required for Cross-Presentation In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Steady-state and inflammatory dendritic-cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Recognition and signaling by toll-like receptors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Activation of nuclear factor-kappaB in macrophages by mycoplasmal lipopeptides.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

CD36 is a sensor of diacylglycerides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Helper T cells, dendritic cells and CTL Immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

IFN-alpha/beta-dependent cross-priming induced by specific toll-like receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Dendritic cells in a mature age.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

PD-1 signaling in primary T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Mice lacking MHC class II molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939790

7 January 2021

Identifiers

DOI

10.1002/EJI.200939790

1 reference

14 November 2017

1 reference